$EOLS news
The latest EOLS stock news: headlines, filings, AI summaries and sentiment for $EOLS, updated around the clock.
- Pomerantz Law Firm Investigates Evolus, Inc. Following FDA Warning Regarding Jeuveau Marketing
- Evolus Reports Q3 2026 Revenue Growth Driven by Toxins and Fillers
- Evolus Reaffirms 2026 Revenue Guidance and Sets Long-Term 2028 Targets
- Evolus, Inc. - 10-Q Filing
- Evolus Reports Q3 Revenue Beat Amid GAAP EPS Miss
- Evolus, Inc. - 8-K Filing
- Pomerantz Law Firm Investigates Evolus, Inc. Following FDA Warning Letter
- Evolus Receives FDA Warning Over Misleading Social Media Post for Jeuveau